- Home
- VRDN vs SFL Comparison
VRDN vs SFL Comparison
Compare VRDN & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- SFL
- Stock Information
- Founded
- VRDN 2006
- SFL 2003
- Country
- VRDN United States
- SFL Bermuda
- Employees
- VRDN N/A
- SFL N/A
- Industry
- VRDN Medical Specialities
- SFL Marine Transportation
- Sector
- VRDN Health Care
- SFL Consumer Discretionary
- Exchange
- VRDN Nasdaq
- SFL Nasdaq
- Market Cap
- VRDN 1.5B
- SFL 1.5B
- IPO Year
- VRDN N/A
- SFL N/A
- Fundamental
- Price
- VRDN $18.13
- SFL $10.85
- Analyst Decision
- VRDN Buy
- SFL Strong Buy
- Analyst Count
- VRDN 12
- SFL 2
- Target Price
- VRDN $36.44
- SFL $14.50
- AVG Volume (30 Days)
- VRDN 1.6M
- SFL 963.3K
- Earning Date
- VRDN 02-25-2025
- SFL 02-28-2025
- Dividend Yield
- VRDN N/A
- SFL 9.96%
- EPS Growth
- VRDN N/A
- SFL 39.68
- EPS
- VRDN N/A
- SFL 1.10
- Revenue
- VRDN $302,000.00
- SFL $876,068,000.00
- Revenue This Year
- VRDN $2.55
- SFL $21.02
- Revenue Next Year
- VRDN N/A
- SFL N/A
- P/E Ratio
- VRDN N/A
- SFL $9.87
- Revenue Growth
- VRDN N/A
- SFL 19.50
- 52 Week Low
- VRDN $11.40
- SFL $9.64
- 52 Week High
- VRDN $27.20
- SFL $14.62
- Technical
- Relative Strength Index (RSI)
- VRDN 44.39
- SFL 59.72
- Support Level
- VRDN $16.60
- SFL $10.30
- Resistance Level
- VRDN $21.58
- SFL $11.14
- Average True Range (ATR)
- VRDN 1.00
- SFL 0.24
- MACD
- VRDN -0.16
- SFL 0.09
- Stochastic Oscillator
- VRDN 30.72
- SFL 74.79
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship owning and chartering company. The company is engaged primarily in the ownership and operation of vessels and offshore related assets and is also involved in the charter, purchase, and sale of assets. Its oil tankers, chemical tankers, and oil product tankers are all double-hull vessels.